The Joint Clinical Research Board (JCRB) is a formal part of the structures of both Queen Mary and Barts Health.
The JCRB was established in 2016 by Barts Health and QMUL to provide assurance to both the Trust Board and Queen Mary's Senior Executive (QMSE) that our research is being carried out in accordance with:
- BartsHealth and Queen Mary strategy and policy
- Legal and regulatory requirements
- Financial regulations, and
- The JCRB's formal Terms of Reference [PDF 172KB]
Its remit includes all clinical research at Barts Health and Queen Mary's School of Medicine and Dentistry, with a particular focus on research involving human subjects and tissues. It will, from time to time, set R&D activity targets and monitor progress in achieving them.
The JCRB is accountable directly to the Trust Board and to QMSE, via the Clinical and Academic Strategy Board and the School of Medicine and Dentistry’s Senior Executive Group (SMD-SEG) respectively.
- December 2018 minutes will be added once agreed at the March meeting
- September 2018 [PDF 278KB]
- June 2018 [PDF 358KB]
- March 2018 [PDF 553KB]
- December 2017 [PDF 344KB]
- September 2017 [PDF 371KB]
- June 2017. [PDF 387KB]
- March 2017 [PDF 369KB]
- December 2016 [PDF 373KB]
- September 2016 [PDF 348KB]
Future planned meetings
- 18 March 2019
- 17 June 2019
- 16 September 2019
- 9 December 2019
- 16 March 2020 (TBC)
If you have any questions about the JCRB please contact the Board's Secretary Nick Good, R&D Projects Manager: email@example.com.